Does Computed Tomography or Positron Emission Tomography/Computed Tomography Contribute to Detection of Small Focal Cancers in the Prostate?

Michael M. Li, Maxim Rybalov, Masoom A. Haider, Igle J. de Jong*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)

Abstract

Prostate cancer is considered to be a multifocal tumor in the majority of patients. Based on histologic data after prostatectomy, there is a growing insight that a considerable number of men who receive a diagnosis in the contemporary setting of prostate-specific antigen screening have unilateral or unifocal disease. With this, the current concept of whole-gland therapy has come into discussion. The need for improvement of intraprostatic tumor characterization is clear. Molecular imaging is one of the areas of research on this aspect. The clinical indications for positron emission tomography (PET)/CT have increased rapidly in the field of oncology and are largely based on fluorodeoxyglucose (FDG) PET. Both conventional CT and FDG PET, however, cannot detect prostate cancer foci

Original languageEnglish
Pages (from-to)693-700
Number of pages8
JournalJournal of endourology
Volume24
Issue number5
DOIs
Publication statusPublished - May-2010

Keywords

  • TUMOR ANGIOGENESIS
  • TRANSRECTAL ULTRASONOGRAPHY
  • C-11-CHOLINE PET/CT
  • DYNAMIC CT
  • BLOOD-FLOW
  • LOCALIZATION
  • CARCINOMA
  • RADIATION
  • TISSUE
  • MRI

Cite this